argenx and AbbVie to Collaborate on ARGX-115 Against Novel Immuno-Oncology Target

Tuesday, April 19, 2016 1 min read

Key Takeaway: argenx and AbbVie to Collaborate on ARGX-115 Against Novel Immuno-Oncology Target

Full Press Release Details

argenx and AbbVie to Collaborate on ARGX-115 Against Novel Immuno-Oncology Target.